law://eu/reg/2017/455@2026-11-17THE EUROPEAN COMMISSION,Having regard to the Treaty on the Functioning of the European Union,Having regard to Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in animal nutritionnote, and in particular Article 9(2) thereof,Whereas:
HAS ADOPTED THIS REGULATION:
| Identification number of the additive | Name of the holder of authorisation | Additive | Composition, chemical formula, description, analytical method | Species or category of animal | Maximum age | Minimum content | Maximum content | Other provisions | End of period of authorisation |
|---|---|---|---|---|---|---|---|---|---|
| CFU of additive/kg of feed material | |||||||||
| 1a001 | — | Lactobacillus fermentum (NCIMB 41636), Lactobacillus plantarum (NCIMB 41638) and Lactobacillus rhamnosus (NCIMB 41640) | Additive compositionPreparation of Lactobacillus fermentum (NCIMB 41636), Lactobacillus plantarum (NCIMB 41638) and Lactobacillus rhamnosus (NCIMB 41640) containing a minimum of total Lactobacilli of 1,0 × 108 CFU/g additive (having a minimum of each Lactobacillus of 1,0 × 107 CFU/g additive)Characterisation of the active substanceViable cells of Lactobacillus fermentum (NCIMB 41636), Lactobacillus plantarum (NCIMB 41638) and Lactobacillus rhamnosus (NCIMB 41640)Analytical methodnoteEnumeration in the feed additive: spread plate method on MRS agar (EN 15787)Identification: Pulsed Field Gel Electrophoresis (PFGE). | Dogs | — |
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.
| — |
| 1.In the directions for use of the additive and premixture, indicate the storage conditions.2.This additive shall be used only in oat derived products and pasteurised milk.3.Recommended use levels of additive:6 × 108 CFU/kg of oat derived products (90 % moisture content);2,7 × 1010 CFU/kg of pasteurised milk.4.For users of the additive and premixtures, feed business operators shall establish operational procedures and appropriate organisational measures to address the potential risks by inhalation, dermal contact or eyes contact. Where risks cannot be reduced to an acceptable level by these procedures and measures, the additive and premixtures shall be used with appropriate personal protective equipment, including skin protection. |
| 5 April 2027 |